Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR   US68827R1086

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/20/2015 04/21/2015 04/22/2015 04/23/2015 04/24/2015 Date
16.35(c) 16.45(c) 16.35(c) 16.59(c) 16.33(c) Last
188 082 108 553 103 477 103 041 47 592 Volume
-0.12% +0.61% -0.61% +1.47% -1.57% Change
More quotes
Financials ($)
Sales 2015 91,7 M
EBIT 2015 10,3 M
Net income 2015 16,0 M
Debt 2015 -
Yield 2015 -
Sales 2016 115 M
EBIT 2016 22,5 M
Net income 2016 35,0 M
Debt 2016 -
Yield 2016 -
PER 2015 35,50
PER 2016 16,66
Capi. / Sales 2015 6,12x
Capi. / Sales 2016 4,89x
Capitalization 561 M
More Financials
Company
Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets.The company operates its business through two segments: Therapeutics and Biosurgery segment.The... 
More about the company
Surperformance© ratings of Osiris Therapeutics, Inc.
Trading Rating : - Investor Rating :
More Ratings
Latest news on OSIRIS THERAPEUTICS, INC.
04/21 OSIRIS THERAPEUTICS : Change in Directors or Principal Officers (form 8-K)
04/17 OSIRIS THERAPEUTICS : Announces First Quarter 2015 Financial Results Conference ..
04/15 OSIRIS THERAPEUTICS : Announces Alla Danilkovitch, Ph.D., as Chief Scientific Of..
04/09 OSIRIS THERAPEUTICS : Change in Directors or Principal Officers, Financial State..
04/09 OSIRIS THERAPEUTICS : Announces Alla Danilkovitch, Ph.D., as Chief Scientific Of..
04/08 OSIRIS THERAPEUTICS : Other Events (form 8-K)
03/23 OSIRIS THERAPEUTICS : to Present at the 3rd Annual Regen Med Investor Day
03/20 OSIRIS THERAPEUTICS : Management's Discussion and Analysis of Financial Conditio..
More news
Sector news : Bio Therapeutic Drugs
04/23 MEDIVATION : Announces First Quarter 2015 Financial Results Teleconference on Ma..
04/23 ALKERMES : to Host Conference Call to Discuss First Quarter 2015 Financial Resul..
04/23DJAbbVie Profit Rises on Broad Sales Growth -- Update
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
04/09 WHY INVESTORS SHOULDN'T WORRY ABOUT : Maxim's Jason Kolbert
03/30 Stryker And Osiris Step Into The Bony Void
03/05 Osiris Therapeutics' (OSIR) CEO Lode Debrabandere on Q4 2014 Results - Earnin..
03/05 Osiris Therapeutics ups revenues 147% in FY14
03/05 Osiris Therapeutics (OSIR) Q4 2014 Results - Earnings Call Webcast


Comments 
Advertisement
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF